BioBreyer
Santo André
About BioBreyer
BioBreyer focuses on research and development in the field of biotechnology in topics related to health and industrial biotechnology. BioBreyer promotes technological development through results obtained in academic research. The company's flagship is the development of a new generation of the bioparticular asparaginase. Asparaginase is used in the treatment of leukemias, especially acute lymphoid leukemia in children and adolescents. The proposal is to develop an asparagine that has fewer adverse effects, which provides greater efficiency in the treatment and improves the quality of life of the patient.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Oct 2022)
- Website: biobreyer.com.br
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/biobreyer-2742356 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.